In lung cancer, double or multiple EGFR mutations were observed in CTCs of patients with non-small-cell lung cancer, which indicated CTC mutation heterogeneity.27, 28 In pancreatic cancer, the presence of various KRAS mutations in codons 12 and 13 in CTCs indicated heterogeneity.29 The gene discussed is KRAS; the disease is familial pancreatic carcinoma.